Optimizing the use of vilobelimab for the treatment of COVID-19
.
Source: Expert Opinion on Biological Therapy - Category: Drugs & Pharmacology Authors: Matthew W McCarthyDepartment of Medicine, Weill Cornell Medicine, New York, NY, United States of America Source Type: research